⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28556948 | 0.98 | NOS1 (0.47) | — | |
| SCHEMBL4517927 | 0.78 | — | — | |
| SCHEMBL402280 | 0.78 | — | — | |
| SCHEMBL4517923 | 0.74 | — | — | |
| SCHEMBL8545489 | 0.71 | — | — | |
| SCHEMBL9601627 | 0.71 | — | — | |
| SCHEMBL3918994 | 0.71 | NOS1 (0.33) | — | |
| SCHEMBL3983133 | 0.70 | NOS1 (0.32) | — | |
| SCHEMBL3912744 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL4755774 | 0.70 | ELANE (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115772132-A | Amidine/guanidino modified fungal CYP51 inhibitor derivative, and preparation method and application thereof | 山东大学 | 2023-03-10 | — | — | CN | claimed |
| CN-111269149-B | Production process of 5- (3,3-dimethylguanidino) -2-oxopentanoic acid | 南京优氟医药科技有限公司 | 2022-04-15 | — | — | CN | claimed |
| WO-2025119337-A1 | ANTIVIRAL CONJUGATE | 苏州拓界医药有限公司 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025103493-A1 | CANNABINOID RECEPTOR 1 ANTAGONIST AND USE THEREOF | 西藏海思科制药有限公司 | 2025-05-22 | — | — | WO | disclosed |
| WO-2025002421-A1 | CONJUGATE FOR PREVENTING AND TREATING VIRAL INFECTION AND USE THEREOF | 上海爱科百发生物医药技术股份有限公司 | 2025-01-02 | — | — | WO | disclosed |
| WO-2023125806-A1 | CONJUGATE FOR PREVENTING AND TREATING VIRAL INFECTIONS AND USE THEREOF | 苏州爱科百发生物医药技术有限公司 | 2023-07-06 | — | — | WO | disclosed |
| CN-115894617-A | Polypeptide compound and application thereof | 成都诺和晟泰生物科技有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-115772132-A | Amidine/guanidino modified fungal CYP51 inhibitor derivative, and preparation method and application thereof | 山东大学 | 2023-03-10 | — | — | CN | disclosed |
| CN-111662232-B | Small molecule compound with 2H-indazole structure and synthesis and application thereof | 中国科学院上海药物研究所 | 2022-08-02 | — | — | CN | disclosed |
| CN-114746418-A | Monocyclic beta-lactam compounds and uses thereof | 苏州信诺维医药科技股份有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-112175042-B | Method for synthesizing Etelcalcetide | 深圳翰宇药业股份有限公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-107573275-A | Cinnamamide derivative | 日本脏器制药株式会社 | 2018-01-12 | — | — | CN | disclosed |
| CN-103476252-B | Pyrazolyl guanidine F1F 0-ATPase inhibitors and therapeutic uses thereof | 莱斯拉公司 | 2017-02-22 | — | — | CN | disclosed |
| US-9540338-B2 | Substituted cinnamic acid amides for treating pain | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2017-01-10 | — | — | US | disclosed |
| US-20150322024-A1 | Cinnamic Acid Amide Derivative | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2015-11-12 | — | — | US | disclosed |
| EP-2940003-A1 | CINNAMIC ACID AMIDE DERIVATIVE | Nippon Zoki Pharmaceutical Co., Ltd. (JP) | 2015-11-04 | — | — | EP | disclosed |
| CN-104884426-A | Cinnamide derivative | NIPPON ZOKI PHARMACEUCTICAL CO LTD | 2015-09-02 | — | — | CN | disclosed |
| CN-103476252-A | Pyrazolyl guanidines F1F0Inhibitors of ATPase and therapeutic uses thereof | LYCERA CORP | 2013-12-25 | — | — | CN | disclosed |
| EP-2026754-A2 | LIGHTENING AND/OR COLOURING AGENT COMPRISING CYCLIC UREA DERIVATIVES | Henkel AG & Co. KGaA (DE) | 2009-02-25 | — | — | EP | disclosed |
| WO-2007137676-A2 | LIGHTENING AND/OR COLOURING AGENT COMPRISING CYCLIC UREA DERIVATIVES | HENKEL AG & CO. KGAA (DE) | 2007-12-06 | — | — | WO | disclosed |